The Tuberculosis Testing and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segment by Type, covers
Smear Microscopy
Nucleic Acid Testing
Radiography
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others
Market segment by Application can be divided into
Hospitals and Clinics
Diagnostic Laboratories
Others
The key market players for global Tuberculosis Testing and Diagnostics market are listed below:
Roche
Thermo Fischer Scientific
Becton Dickinson
Abbott
Hologic
Qiagen
Sanofi
Oxford Immunotec
BioMerieux
Par Sterile
Bio-Rad Laboratories
Akonni Biosystems
Cepheid
Siemens Healthineer
Hain Lifescience
Epistem
Creative Diagnostics
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.globalinforesearch.com/reports/831155/tuberculosis-testing-diagnostics
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Testing and Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Testing and Diagnostics, with price, sales, revenue and global market share of Tuberculosis Testing and Diagnostics from 2019 to 2022.
Chapter 3, the Tuberculosis Testing and Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Testing and Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, end user, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Testing and Diagnostics market forecast, by regions, type and end user, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Testing and Diagnostics.
Chapter 13, 14, and 15, to describe Tuberculosis Testing and Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Tuberculosis Testing and Diagnostics
1.2 Classification of Tuberculosis Testing and Diagnostics by Type
1.2.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Type in 2021
1.2.3 Smear Microscopy
1.2.4 Nucleic Acid Testing
1.2.5 Radiography
1.2.6 Tuberculin Skin Test (TST)
1.2.7 Interferon Gamma Released Assay (IGRA)
1.2.8 Others
1.3 Global Tuberculosis Testing and Diagnostics Market by Application
1.3.1 Overview: Global Tuberculosis Testing and Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Tuberculosis Testing and Diagnostics Market Size & Forecast
1.5 Global Tuberculosis Testing and Diagnostics Market Size and Forecast by Region
1.5.1 Global Tuberculosis Testing and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Tuberculosis Testing and Diagnostics Market Size by Region, (2017-2022)
1.5.3 North America Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.4 Europe Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.6 South America Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Tuberculosis Testing and Diagnostics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis Testing and Diagnostics Market Drivers
1.6.2 Tuberculosis Testing and Diagnostics Market Restraints
1.6.3 Tuberculosis Testing and Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Tuberculosis Testing and Diagnostics Product and Solutions
2.1.4 Roche Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche Recent Developments and Future Plans
2.2 Thermo Fischer Scientific
2.2.1 Thermo Fischer Scientific Details
2.2.2 Thermo Fischer Scientific Major Business
2.2.3 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Product and Solutions
2.2.4 Thermo Fischer Scientific Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Tuberculosis Testing and Diagnostics Product and Solutions
2.3.4 Becton Dickinson Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Tuberculosis Testing and Diagnostics Product and Solutions
2.4.4 Abbott Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Tuberculosis Testing and Diagnostics Product and Solutions
2.5.4 Hologic Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Hologic Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Tuberculosis Testing and Diagnostics Product and Solutions
2.6.4 Qiagen Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Qiagen Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Tuberculosis Testing and Diagnostics Product and Solutions
2.7.4 Sanofi Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Oxford Immunotec
2.8.1 Oxford Immunotec Details
2.8.2 Oxford Immunotec Major Business
2.8.3 Oxford Immunotec Tuberculosis Testing and Diagnostics Product and Solutions
2.8.4 Oxford Immunotec Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Oxford Immunotec Recent Developments and Future Plans
2.9 BioMerieux
2.9.1 BioMerieux Details
2.9.2 BioMerieux Major Business
2.9.3 BioMerieux Tuberculosis Testing and Diagnostics Product and Solutions
2.9.4 BioMerieux Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BioMerieux Recent Developments and Future Plans
2.10 Par Sterile
2.10.1 Par Sterile Details
2.10.2 Par Sterile Major Business
2.10.3 Par Sterile Tuberculosis Testing and Diagnostics Product and Solutions
2.10.4 Par Sterile Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Par Sterile Recent Developments and Future Plans
2.11 Bio-Rad Laboratories
2.11.1 Bio-Rad Laboratories Details
2.11.2 Bio-Rad Laboratories Major Business
2.11.3 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Product and Solutions
2.11.4 Bio-Rad Laboratories Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.12 Akonni Biosystems
2.12.1 Akonni Biosystems Details
2.12.2 Akonni Biosystems Major Business
2.12.3 Akonni Biosystems Tuberculosis Testing and Diagnostics Product and Solutions
2.12.4 Akonni Biosystems Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Akonni Biosystems Recent Developments and Future Plans
2.13 Cepheid
2.13.1 Cepheid Details
2.13.2 Cepheid Major Business
2.13.3 Cepheid Tuberculosis Testing and Diagnostics Product and Solutions
2.13.4 Cepheid Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Cepheid Recent Developments and Future Plans
2.14 Siemens Healthineer
2.14.1 Siemens Healthineer Details
2.14.2 Siemens Healthineer Major Business
2.14.3 Siemens Healthineer Tuberculosis Testing and Diagnostics Product and Solutions
2.14.4 Siemens Healthineer Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Siemens Healthineer Recent Developments and Future Plans
2.15 Hain Lifescience
2.15.1 Hain Lifescience Details
2.15.2 Hain Lifescience Major Business
2.15.3 Hain Lifescience Tuberculosis Testing and Diagnostics Product and Solutions
2.15.4 Hain Lifescience Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Hain Lifescience Recent Developments and Future Plans
2.16 Epistem
2.16.1 Epistem Details
2.16.2 Epistem Major Business
2.16.3 Epistem Tuberculosis Testing and Diagnostics Product and Solutions
2.16.4 Epistem Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Epistem Recent Developments and Future Plans
2.17 Creative Diagnostics
2.17.1 Creative Diagnostics Details
2.17.2 Creative Diagnostics Major Business
2.17.3 Creative Diagnostics Tuberculosis Testing and Diagnostics Product and Solutions
2.17.4 Creative Diagnostics Tuberculosis Testing and Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Creative Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Tuberculosis Testing and Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Tuberculosis Testing and Diagnostics Players Market Share in 2021
3.2.2 Top 10 Tuberculosis Testing and Diagnostics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Tuberculosis Testing and Diagnostics Players Head Office, Products and Services Provided
3.4 Tuberculosis Testing and Diagnostics Mergers & Acquisitions
3.5 Tuberculosis Testing and Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Tuberculosis Testing and Diagnostics Revenue and Market Share by Type (2017-2022)
4.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Tuberculosis Testing and Diagnostics Revenue Market Share by Application (2017-2022)
5.2 Global Tuberculosis Testing and Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
6.2 North America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
6.3 North America Tuberculosis Testing and Diagnostics Market Size by Country
6.3.1 North America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
6.3.2 United States Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
6.3.3 Canada Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
6.3.4 Mexico Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
7.2 Europe Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
7.3 Europe Tuberculosis Testing and Diagnostics Market Size by Country
7.3.1 Europe Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
7.3.2 Germany Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.3 France Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.5 Russia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
7.3.6 Italy Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
8.2 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
8.3 Asia-Pacific Tuberculosis Testing and Diagnostics Market Size by Region
8.3.1 Asia-Pacific Tuberculosis Testing and Diagnostics Revenue by Region (2017-2028)
8.3.2 China Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.3 Japan Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.4 South Korea Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.5 India Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
8.3.7 Australia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
9.2 South America Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
9.3 South America Tuberculosis Testing and Diagnostics Market Size by Country
9.3.1 South America Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
9.3.2 Brazil Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
9.3.3 Argentina Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Type (2017-2028)
10.2 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Application (2017-2028)
10.3 Middle East & Africa Tuberculosis Testing and Diagnostics Market Size by Country
10.3.1 Middle East & Africa Tuberculosis Testing and Diagnostics Revenue by Country (2017-2028)
10.3.2 Turkey Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
10.3.4 UAE Tuberculosis Testing and Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
